Optimal Anti-Thrombotic Management Following Percutaneous Left Atrial Appendage Occlusion
Optimal Anti-Thrombotic Management Following Percutaneous Left Atrial Appendage Occlusion
Recruiting · NCT07840365 · Registry updated 2026-10-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Optimal Anti-Thrombotic Management Following Percutaneous Left Atrial Appendage Occlusion | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder | Recruiting | Phase 3 | 2026-10-05 | NCT07840365 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Texas Cardiac Arrhythmia Research Foundation | 4 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Texas Cardiac Arrhythmia Institute, St. David's Medical Center | Austin | United States | 2 |